Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| KC-IPM-REDI | Mar 2026 | 99.6% | Freedom Diagnostics | — | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. Ipamorelin is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Kimera Chems sell Ipamorelin?
Kimera Chems has 9 COAs on file for Ipamorelin but no active price listing is currently tracked.
Is Kimera Chems's Ipamorelin third-party tested?
Yes — Disclosed Labs has indexed 9 Certificates of Analysis for Kimera Chems's Ipamorelin, with the most recent showing 99.6% purity. Kimera Chems holds an overall trust grade of C (70/100) across all 355 COAs on file.
What is Kimera Chems's trust grade for Ipamorelin?
Kimera Chems has an overall Disclosed Labs trust grade of C (70/100), computed from 355 COAs across all peptides. The most recent Ipamorelin COA was issued by Freedom Diagnostics.
Where is the cheapest Ipamorelin?
As of the latest data, Peptide Supply Co. offers Ipamorelin at $2.70/mg — compare with Kimera Chems's listing. See the full Ipamorelin price comparison.
Is Ipamorelin legal to buy?
Ipamorelin is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| KC-CIB-BLU2 | Mar 2026 | 99.9% | Freedom Diagnostics | — | Confirmed | View |
| — | Oct 2025 | 99.9% | Freedom Diagnostics | — | Confirmed | View |
| White Cap | Nov 2024 | 99.8% | Vanguard Laboratory | — | Unverified | View |
| KC-CIB-ORG1 | — | 99.6% | TrustPointe Analytics | Sterility | Confirmed | View |
| Blue Cap | — | 99.3% | Vanguard Laboratory | — | Unverified | View |
| Yellow Cap | — | 99.8% | Vanguard Laboratory | — | Unverified | View |
| KC-IPM-BLK1 | — | 100.0% | TrustPointe Analytics | — | Confirmed | View |
| KC-IPM-WHT1 | — | 99.8% | TrustPointe Analytics | — | Confirmed | View |